Published on February 10, 2014

The agony of rejection of drugs from major plants has been haunting the Ranbaxy officials. Post this issue there started a series of verbal altercation between the employer and employee. Company said that some of the employees are doing it intentionally to defame the company name in international market. On the other side employees were furious on this cover-up act of management. Government has advised the company to focus on their basics and should strict actions to comply with the standardized norms and regulations.

In a recent move Gujarat based Cadila got approval from USFDA to market arthritis drugs in USA. Company has now 88 approvals and has filed around 216 abbreviated new drug applications (ANDAs). India has signed bilateral trade with Zimbabwe. Now India will be exporting many of its pharma products, chemicals, machinery, electronic goods and plastic to the African country.

Recently pharma association had shown its disagreement over the governments lethargic attitude towards health and pharma related bills. In view of the elections in April-May, future of several pending bills related to health and pharma sector is under bleak. As expected government will focus more on those bills which can lure the masses and will help them to gain more popularity. Major bills related to this industry will be again abandoned and will have to wait until the new government is formed. Such kind of lackluster attitude dispirits the growth of industry to a great extent.